FOXC1 and glaucoma: Although expression of FOXC1 is yet to be studied in adults, it is highly possible that continued expression of the abnormal gene product (from age-related, subclinical mutations) throughout life, or altered levels of expression of FOXC1 could interfere with normal function of the TM, thereby leading to increased risk of glaucoma through the effects of raised IOP.